Tan, Silvestra R.

HRN: 09-79-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/18/2026
08/25/2026
IV
500MG
Q8hrs
Infectious Diarrhea (E. Histolytica)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: